In DCCT, participants were randomised to either intensive or conventional insulin therapy (achieving a median HbA 1c level of 7% vs 9% [53 vs 75 mmol/mol], respectively) and followed for a mean of 6.5 years
Gerkowicz SA, Curtis SW, Knight AK, Cobb DO, Spencer JB, Conneely KN, et al
She advises doctors to be proactive in monitoring the risk in GLP-1 patients, especially in postmenopausal women and men over age 50 who would already be at higher risk of bone loss due to their age
A core function of a firms quality unit is to provide adequate oversight for the manufacture and release of products in compliance with cGMP
Cosmetic is not approved drug. Preclinical is not proven in humans. And a blend of four things with animal-level evidence does not become clinically validated by virtue of being mixed together
Packs like the CNHL G+ series demonstrate how modern manufacturing and honest specifications can deliver both power and value